Conclusion
In conclusion, the application and development of network pharmacology
have excavated new insights into the treatment of sepsis, including the
treatment mechanism of the disease: the complex network relationship of
multi-target, multi-channel, and multi-component, which also makes us a
new way of thinking for the drug development and selection of this
refractory disease. In addition, it also shows attractive charm in the
treatment of complex diseases such as cancer, cardiovascular disease,
mental disease, and new coronavirus pneumonia. However, network
pharmacology still faces many problems and challenges, such as the lack
of uniformity in the diversity of databases, the lack of standardization
in data screening, and the poor repeatability and convertibility of data
results. Although the development of computer science, genomics, and
systems biology may promote the development of network pharmacology in
more disease fields, it is still necessary to explore new methods for
the treatment of complex diseases such as sepsis.